Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,061 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of tauromustine in disseminated malignant melanoma.
Nolte H, Gjedde SB, Lindegaard-Madsen E, Bergh J, Blomquist E, Mouridsen HT. Nolte H, et al. Among authors: bergh j. Eur J Cancer Clin Oncol. 1989 Apr;25(4):655-7. doi: 10.1016/0277-5379(89)90201-0. Eur J Cancer Clin Oncol. 1989. PMID: 2714342
Phase I study of tauromustine administered in a weekly schedule.
Gjedde SB, Mouridsen HT, L-Madsen E, Jensen NV, Blomquist E, Bergh J, Söderberg M, Wählby S. Gjedde SB, et al. Among authors: bergh j. Eur J Cancer. 1993;29A(13):1901-2. doi: 10.1016/0959-8049(93)90547-s. Eur J Cancer. 1993. PMID: 8260251 Clinical Trial.
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.
Sjöström J, Blomqvist C, Mouridsen H, Pluzanska A, Ottosson-Lönn S, Bengtsson NO, Ostenstad B, Mjaaland I, Palm-Sjövall M, Wist E, Valvere V, Anderson H, Bergh J. Sjöström J, et al. Among authors: bergh j. Eur J Cancer. 1999 Aug;35(8):1194-201. doi: 10.1016/s0959-8049(99)00122-7. Eur J Cancer. 1999. PMID: 10615229 Clinical Trial.
Phase II study of tauromustine in disseminated malignant melanoma.
Gjedde SB, Mouridsen HT, L-Madsen E, Jensen NV, Blomquist E, Bergh J, Söderberg M, Wählby S. Gjedde SB, et al. Among authors: bergh j. Eur J Cancer. 1994;30A(4):566. doi: 10.1016/0959-8049(94)90448-0. Eur J Cancer. 1994. PMID: 8018421 Clinical Trial. No abstract available.
1,061 results